(Q40542266)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26367221%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

title

Second allogeneic transplantation for relapse of malignant disease: retrospective analysis of outcome and predictive factors by the EBMT (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26367221%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26367221%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Stefan Schönland

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26367221%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

8

C Peters

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26367221%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

author name string

T Ruutu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26367221%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

A van Biezen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26367221%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

R Brand

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26367221%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

M Mohty

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26367221%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

P Dreger

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26367221%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

R Duarte

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26367221%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

L Garderet

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26367221%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

A Gratwohl

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26367221%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

D Niederwieser

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26367221%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

T de Witte

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26367221%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

N Kröger

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26367221%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

European Society for Blood and Marrow Transplantation (EBMT)

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26367221%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

language of work or name

English

0 references

publication date

14 September 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26367221%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

24 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26367221%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

volume

50

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26367221%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26367221%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

page(s)

1542-1550

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26367221%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/bmt.2015.186

24 February 2020

exact match

0 references

cites work

Outcomes among patients with recurrent high-risk hematologic malignancies after allogeneic hematopoietic cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.186

Prevention and treatment of acute myeloid leukemia relapse after allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.186

Donor leukocyte transfusions for treatment of leukemic relapse after bone marrow transplantation. EBMT Immunology and Chronic Leukemia Working Parties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.186

Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.186

Second hematopoietic stem cell transplantation in myeloid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.186

Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.186

Second allograft for hematologic relapse of acute leukemia after first allogeneic stem-cell transplantation from related and unrelated donors: the role of donor change

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.186

Management of relapse after allo-SCT for AML and the role of second transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.186

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.186

Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.186

Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.186

Reduced-intensity conditioning with fludarabine and thiotepa for second allogeneic transplantation of relapsed patients with AML

21 January 2018

1 reference

12 December 2020

Second allografts for relapsed hematologic malignancies: feasibility of using a different donor

1 reference

12 December 2020

Second early allogeneic stem cell transplantations for graft failure in acute leukaemia, chronic myeloid leukaemia and aplastic anaemia. French Society of Bone Marrow Transplantation

1 reference

12 December 2020

Second allogeneic bone marrow transplantation in acute leukemia: results of a survey by the European Cooperative Group for Blood and Marrow Transplantation

1 reference

12 December 2020

Second allogeneic bone marrow transplantation for post-transplant leukemia relapse: results of a survey of 66 cases in 24 Japanese institutes

1 reference

12 December 2020

Disease burden may identify patients more likely to benefit from second allogeneic hematopoietic stem cell transplantation to treat relapsed acute myelogenous leukemia

1 reference

12 December 2020

Second allogeneic hematopoietic stem cell transplantation for leukemia relapse after first allogeneic transplantation: outcome of 16 patients in a single institution

1 reference

12 December 2020

Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Societe Francaise de Greffe de Moelle (SFGM)

1 reference

12 December 2020

EBMT Risk Score Predicts Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Who Have Failed a Previous Transplantation Procedure

1 reference

12 December 2020

Second transplants for leukaemic relapse after bone marrow transplantation: high early mortality but favourable effect of chronic GVHD on continued remission. A report by the EBMT Leukaemia Working Party

1 reference

12 December 2020

The role of repeat transplantation of haemopoietic stem cells and adoptive immunotherapy in treatment of leukaemia relapsing following allogeneic transplantation

1 reference

12 December 2020